Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 2 (2024): December

Nano-Chitosan and Aschorbic Acid Synergistically Combat Resistant Staph in Atopic Dermatitis
Nano-Kitosan dan Aschorbic Acid Secara Sinergis Memerangi Staph Resisten pada Dermatitis Atopik



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.9151
Published
June 20, 2024

Abstract

Chitosan, derived from natural sources like fish scales and fungal cell walls, forms nanoparticles (NPs) with notable antimicrobial properties. This study examines the antibacterial effects of ascorbic acid combined with nano-chitosan on Staphylococcus aureus isolates from 100 atopic dermatitis (AD) patients. Using the Vitek 2 Compact device for bacterial identification and antibiotic sensitivity testing, we found that nano-chitosan/ascorbic acid composites significantly inhibited the growth of multidrug-resistant S. aureus. The antimicrobial activity increased with higher concentrations, highlighting the potential of this natural polymer blend as an effective treatment for AD-related bacterial infections.

Highlights:

  1. Effective Inhibition: Nano-chitosan/ascorbic acid inhibits multidrug-resistant Staphylococcus aureus.
  2. AD Focus: Targets S. aureus in atopic dermatitis patients.
  3. Green Alternative: Uses natural, non-toxic antibacterial agents.

Keywords: Chitosan nanoparticles, Ascorbic acid, Staphylococcus aureus, Atopic dermatitis, Antibacterial treatment

References

  1. K. H. Keskinbora and M. A. Jameel, "Nanotechnology applications and approaches in medicine: A review," J. Nanosci. Nanotechnol. Res., vol. 2, no. 2, pp. 6, 2018.
  2. N. Boudouaia, Z. Bengharez, and S. Jellali, "Preparation and characterization of chitosan extracted from shrimp shells waste and chitosan film: Application for Eriochrome black T removal from aqueous solutions," Appl. Water Sci., vol. 9, no. 4, pp. 1-12, 2019.
  3. B. Erdem, E. Kariptas, T. Kaya, S. Tulumoglu, and Ö. Görgülü, "Factors influencing antibacterial activity of chitosan against Aeromonas hydrophila and Staphylococcus aureus," Int. Curr. Pharm. J., vol. 5, no. 5, pp. 45-48, 2016.
  4. A. Kassem, G. M. Ayoub, and L. Malaeb, "Antibacterial activity of chitosan nano-composites and carbon nanotubes: A review," Sci. Total Environ., vol. 668, pp. 566-576, 2019.
  5. R. Jha and R. A. Mayanovic, "A review of the preparation, characterization, and applications of chitosan nanoparticles in nanomedicine," Nanomaterials, vol. 13, no. 8, p. 1302, 2023.
  6. E. M. Khalaf et al., "Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review," Int. J. Biol. Macromol., vol. 231, p. 123354, Mar. 2023.
  7. W. Ma, J. Li, X. Li, Y. Bai, and H. Liu, "Nanostructured substrates as matrices for surface assisted laser desorption/ionization mass spectrometry: A progress report from material research to biomedical applications," Small Methods, vol. 5, no. 10, p. 2100762, 2021.
  8. T. M. Amer et al., "Antibacterial and antioxidative activity of O-amine functionalized chitosan," Carbohydr. Polym., vol. 169, pp. 441-450, 2017.
  9. J. S. S. Ho and S. Molin, "A review of existing and new treatments for the management of hand eczema," J. Cutan. Med. Surg., vol. 27, no. 5, 2023.
  10. M. Reiger, C. Traidl-Hoffmann, and A. U. Neumann, "The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfalls," J. Allergy Clin. Immunol., vol. 145, no. 1, pp. 93-96, 2020.
  11. S. T. Barbaro et al., "Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review," J. Am. Acad. Dermatol., vol. 75, pp. 1038-1044, 2016.
  12. V. Reynaert, J. Gutermuth, and A. Wollenberg, "Nipple eczema: A systematic review and practical recommendations," J. Eur. Acad. Dermatol. Venereol., vol. 37, no. 6, pp. 1149-1159, Jun. 2023.
  13. R. Chovatiya, "Atopic dermatitis (eczema)," JAMA, vol. 329, no. 3, p. 268, 2023.
  14. P. Pouge et al., "Staphylococcus aureus toxins: An update on their pathogenic properties and potential treatments," Toxins, vol. 13, no. 10, p. 677, 2021.
  15. P. H. Sette-de-Souza et al., "Antimicrobial potential of chitosan," Afr. J. Microbiol. Res., vol. 9, no. 3, pp. 147-154, 2015.
  16. O. A. Nazarchuk et al., "Prognostic parameters of the susceptibility of Staphylococcus spp. to aminoglycosides and doxycycline," Wiad. Lek., vol. 73, no. 8, pp. 1615-1619, 2020.
  17. Clinical and Laboratory Standards Institute, "Antimicrobial susceptibility testing standards," M02, M07, and M11, 2020.
  18. M. Sotelo-Boyás et al., "Physicochemical characterization of chitosan nanoparticles and nanocapsules incorporated with lime essential oil and their antibacterial activity against food-borne pathogens," LWT, vol. 77, pp. 15-20, 2017.
  19. A. M. Algammal et al., "Methicillin-resistant Staphylococcus aureus (MRSA): One health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact," Infect. Drug Resist., vol. 13, pp. 3255, 2020.
  20. A. Alzubaidi, "Dynamic assessment of biocidal properties of silicon-chitosan-containing hydrogel," Int. J. Innov. Res. Sci. Eng. Technol., vol. 4, no. 4, pp. 2045-2050, Apr. 2015.
  21. G. Ramachandran et al., "Chitosan/silver nanocomposites enhanced the biofilm eradication in biofilm forming Gram-positive S. aureus," J. King Saud Univ. – Sci., vol. 35, no. 4, p. 102597, May 2023.

Downloads

Download data is not yet available.